INS and Hyperglycemia: Despite the fact that in humans, many issues related to the immunological nature of T1D are still to be solved [11], it is widely accepted that the disease derives from an autoimmune destruction of insulin-producing β cells, resulting in insulin deficiency and hyperglycemia, necessitating lifelong insulin replacement [12].